Cargando…

Human T Cell Leukemia Cell Death by Apoptosis‐inducing Nucleosides from CD57(+) HLA‐DR(bright) Natural Suppressor Cell Line

Apoptosis‐inducing nucleosides (AINs) released from CD57(+)HLA‐DR(bright) natural suppressor (57.DR‐NS) cell line, derived from human decidual tissue, were isolated from 57.DR‐NS cell culture supernatant by the combination of thin‐layer chromatography (TLC) and high‐performance liquid chromatography...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Tsuneatsu, Li, Xiang, Mori, Etsuko, Guo, Maowu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2000
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926391/ https://www.ncbi.nlm.nih.gov/pubmed/10874216 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00992.x

Ejemplares similares

Death of Dr Bright
Publicado: (1859)

Death of Dr. Bright
Publicado: (1859)

Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 Replication
por: May, Megan E., et al.
Publicado: (2020)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

Evolution of the HIV-1 nef gene in HLA-B*57 Positive Elite Suppressors
por: Salgado, Maria, et al.
Publicado: (2010)

CD8(+) T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants
por: Pohlmeyer, Christopher W, et al.
Publicado: (2013)

Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
por: Verschoor, Chris P., et al.
Publicado: (2013)

Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia
por: Podhorecka, Monika, et al.
Publicado: (2015)

Dr Richard Bright (1789—1858)
por: Peitzman, Steven J.
Publicado: (1985)

Dr. Richard Bright and Lake Balaton.
por: Boksay, G
Publicado: (1970)

Dr. Jackson, on the Virtues of Eye-Bright
por: Jackson, Robert
Publicado: (1810)

Dr. Richard Bright: An Ophthalmologist’s Appreciation
por: Chance, Burton
Publicado: (1927)

Protective HLA-B57: T cell and natural killer cell recognition in HIV infection
por: Lobos, Christian A., et al.
Publicado: (2022)

T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP
Publicado: (1989)

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules
Publicado: (1992)

Distinct antibody profiles in HLA-B(∗)57(+), HLA-B(∗)57(−) HIV controllers and chronic progressors
por: Klingler, Jéromine, et al.
Publicado: (2022)

HLA-DR expression on monocytes and the T-cell subset in septic patients
por: Menestrina, N, et al.
Publicado: (2005)

Maintenance of viral suppression in HIV-1–infected HLA-B*57(+) elite suppressors despite CTL escape mutations
por: Bailey, Justin R., et al.
Publicado: (2006)

CD14(+) CD15(−) HLA-DR(−) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
por: Bernsmeier, Christine, et al.
Publicado: (2018)

Antitumor Effect of Sugar-Modified Cytosine Nucleosides on Growth of Adult T-Cell Leukemia Cells in Mice
por: Maeda, Naoyoshi, et al.
Publicado: (2020)

Circulating CD14(+) HLA‐DR (‐/low) myeloid‐derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft‐versus‐host disease
por: Yin, Jin, et al.
Publicado: (2016)

Memory B Cells, the HLA-B*57 Allele and Natural Control of HIV Infection
por: Center, Rob J.
Publicado: (2017)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Dr. Bright on Dropsical Effusion from Liver Disease
Publicado: (1828)

Dr. Bright's Reports of Medical Cases in Guy's Hospital
Publicado: (1828)

Dr Rajnish Juneja – A light burnt bright
por: Kothari, Shyam Sunder, et al.
Publicado: (2019)

HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells
Publicado: (1990)

Immunoregulatory T cells, LFA-3 and HLA-DR in autoimmune thyroid diseases
por: Nada, Aml Mohamed, et al.
Publicado: (2014)

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition
por: Szeto, Christopher, et al.
Publicado: (2020)

IL-6-stimulated CD11b(+)CD14(+)HLA-DR(−) myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
por: Chen, Miao-Fen, et al.
Publicado: (2014)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
por: Enz, Lukas Simon, et al.
Publicado: (2019)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

Unravelling the Proteomics of HLA-B*57:01(+) Antigen Presenting Cells during Abacavir Medication
por: Haukamp, Funmilola Josephine, et al.
Publicado: (2022)

Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in ovarian cancer patients
por: Wu, Liangliang, et al.
Publicado: (2017)

CD33(+) HLA-DR(–) Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14(+) Subset
por: Hassan, Mirhane, et al.
Publicado: (2018)

Intratumoral HLA-DR(−)/CD33(+)/CD11b(+) Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Hasnis, Erez, et al.
Publicado: (2020)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia
por: Nicot, Christophe
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e13c5arhtd6rsh5nqetmiori8g